ES2261229T3 - Uso de spinosad o de una formulacion que comprende spinosad. - Google Patents
Uso de spinosad o de una formulacion que comprende spinosad.Info
- Publication number
- ES2261229T3 ES2261229T3 ES00955247T ES00955247T ES2261229T3 ES 2261229 T3 ES2261229 T3 ES 2261229T3 ES 00955247 T ES00955247 T ES 00955247T ES 00955247 T ES00955247 T ES 00955247T ES 2261229 T3 ES2261229 T3 ES 2261229T3
- Authority
- ES
- Spain
- Prior art keywords
- spinosad
- treatment
- dogs
- dog
- control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 title claims abstract description 54
- 239000005930 Spinosad Substances 0.000 title claims abstract description 54
- 229940014213 spinosad Drugs 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 238000009472 formulation Methods 0.000 title claims abstract description 21
- 241000282326 Felis catus Species 0.000 claims abstract description 29
- 239000002775 capsule Substances 0.000 claims abstract description 11
- 239000006187 pill Substances 0.000 claims abstract description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 241000283073 Equus caballus Species 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 229940126701 oral medication Drugs 0.000 claims abstract description 4
- 206010014143 Ectoparasitic Infestations Diseases 0.000 claims abstract description 3
- 241000009328 Perro Species 0.000 claims abstract 3
- 206010061217 Infestation Diseases 0.000 claims description 16
- 244000078703 ectoparasite Species 0.000 claims description 16
- 239000003826 tablet Substances 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 description 49
- 238000011282 treatment Methods 0.000 description 36
- 241000258242 Siphonaptera Species 0.000 description 25
- 241001465754 Metazoa Species 0.000 description 24
- 229930185156 spinosyn Natural products 0.000 description 24
- 241000238876 Acari Species 0.000 description 15
- 235000013305 food Nutrition 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 12
- 241000258924 Ctenocephalides felis Species 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 241000255925 Diptera Species 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- VGGSULWDCMWZPO-ODEMIOGVSA-N spinosin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=2C(=O)C=C(OC=2C=C1OC)C=1C=CC(O)=CC=1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VGGSULWDCMWZPO-ODEMIOGVSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000007903 gelatin capsule Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000607479 Yersinia pestis Species 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 241000868102 Saccharopolyspora spinosa Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- -1 organophosphates Chemical class 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 241000238631 Hexapoda Species 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- VGGSULWDCMWZPO-UHFFFAOYSA-N flavoayamenin Natural products COC1=CC=2OC(C=3C=CC(O)=CC=3)=CC(=O)C=2C(O)=C1C1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O VGGSULWDCMWZPO-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000012669 liquid formulation Substances 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 241000490513 Ctenocephalides canis Species 0.000 description 3
- 241001674048 Phthiraptera Species 0.000 description 3
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000001984 ectoparasiticidal effect Effects 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 239000002949 juvenile hormone Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000003120 macrolide antibiotic agent Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 3
- 229940070846 pyrethrins Drugs 0.000 description 3
- 239000002728 pyrethroid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 241000283086 Equidae Species 0.000 description 2
- 241000545319 Ixodes canisuga Species 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 235000015111 chews Nutrition 0.000 description 2
- 230000002498 deadly effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 229930014550 juvenile hormone Natural products 0.000 description 2
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007916 tablet composition Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- GUBGYTABKSRVRQ-UHFFFAOYSA-N 2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical compound OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002519 Animal scratch Diseases 0.000 description 1
- 241001425390 Aphis fabae Species 0.000 description 1
- 241001600408 Aphis gossypii Species 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000003917 Dirofilariasis Diseases 0.000 description 1
- 208000031912 Endemic Flea-Borne Typhus Diseases 0.000 description 1
- 241000239183 Filaria Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 206010028282 Murine typhus Diseases 0.000 description 1
- 241000257226 Muscidae Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000819999 Nymphes Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241001481696 Rhipicephalus sanguineus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241001494115 Stomoxys calcitrans Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000013057 ectoparasiticide Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000004920 integrated pest control Methods 0.000 description 1
- 229930191400 juvenile hormones Natural products 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000000668 oral spray Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- BFWPTYMTWQBGHH-RUDMXATFSA-N spinosin a Chemical compound COC1=C(O)C(OC)=CC(\C=C\C(=O)OCC2C(C(O)C(O)C(OC3C(OC(CO)C(O)C3O)C=3C(=C4C(=O)C=C(OC4=CC=3OC)C=3C=CC(O)=CC=3)O)O2)O)=C1 BFWPTYMTWQBGHH-RUDMXATFSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14861899P | 1999-08-12 | 1999-08-12 | |
| US148618P | 1999-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2261229T3 true ES2261229T3 (es) | 2006-11-16 |
Family
ID=22526570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00955247T Expired - Lifetime ES2261229T3 (es) | 1999-08-12 | 2000-08-02 | Uso de spinosad o de una formulacion que comprende spinosad. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6664237B1 (enExample) |
| EP (1) | EP1207756B1 (enExample) |
| JP (2) | JP5046455B2 (enExample) |
| KR (1) | KR100706146B1 (enExample) |
| AT (1) | ATE324039T1 (enExample) |
| AU (1) | AU775488B2 (enExample) |
| BE (1) | BE2011C013I2 (enExample) |
| BR (1) | BR0013116B1 (enExample) |
| CA (1) | CA2379329C (enExample) |
| CO (1) | CO5410187A1 (enExample) |
| CY (1) | CY1105000T1 (enExample) |
| DE (2) | DE122011100022I1 (enExample) |
| DK (1) | DK1207756T3 (enExample) |
| ES (1) | ES2261229T3 (enExample) |
| FR (1) | FR11C0017I2 (enExample) |
| HU (1) | HUP0202825A2 (enExample) |
| IL (2) | IL147828A0 (enExample) |
| MX (1) | MXPA02001505A (enExample) |
| MY (1) | MY125485A (enExample) |
| NO (1) | NO20020686L (enExample) |
| NZ (1) | NZ516790A (enExample) |
| PT (1) | PT1207756E (enExample) |
| TW (1) | TWI244373B (enExample) |
| WO (1) | WO2001011963A1 (enExample) |
| ZA (1) | ZA200200565B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6933318B1 (en) | 1999-08-12 | 2005-08-23 | Eli Lilly And Company | Topical organic ectoparasiticidal formulations |
| AUPQ441699A0 (en) | 1999-12-02 | 2000-01-06 | Eli Lilly And Company | Pour-on formulations |
| DE10135550A1 (de) * | 2001-07-20 | 2003-01-30 | Bayer Cropscience Ag | Verfahren zum Herstellen von neuen Spinosyn-Derivaten |
| US7772194B2 (en) | 2001-09-17 | 2010-08-10 | Eli Lilly And Company | Pesticidal formulations |
| ES2315740T3 (es) * | 2003-11-04 | 2009-04-01 | Intervet International Bv | Formulaciones ectoparasiticidas de espinosinas y pesticidas de azol. |
| CN102558082B (zh) | 2004-03-05 | 2015-09-30 | 日产化学工业株式会社 | 异噁唑啉取代苯甲酰胺化合物的制备中间体 |
| JP4880589B2 (ja) * | 2004-04-29 | 2012-02-22 | イーライ リリー アンド カンパニー | 創傷治癒のためのスピノシンの使用 |
| SG159395A1 (en) * | 2004-04-29 | 2010-03-30 | Lilly Co Eli | Use of spinosyns for wound healing |
| AU2006249441A1 (en) | 2005-05-26 | 2006-11-30 | Eli Lilly And Company | Improved fish production |
| KR100855417B1 (ko) * | 2006-10-27 | 2008-08-29 | 일라이 릴리 앤드 캄파니 | 스피노신을 포함하는 상처 치유용 제약 조성물 |
| CA2971008A1 (en) | 2007-06-27 | 2008-12-31 | E. I. Du Pont De Nemours And Company | Animal pest control method |
| US9820977B2 (en) | 2008-10-03 | 2017-11-21 | Bayer Healthcare Llc | Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
| UA108200C2 (uk) * | 2009-05-08 | 2015-04-10 | Лікарські форми та способи застосування ектопаразитоцидів | |
| AU2013273709B2 (en) * | 2009-05-08 | 2015-04-23 | Eli Lilly And Company | Ectoparasiticidal methods and formulations |
| TWI510189B (zh) * | 2009-06-19 | 2015-12-01 | Lilly Co Eli | 殺外寄生蟲之方法及調配物 |
| EP2445506B1 (en) | 2009-06-24 | 2014-12-31 | Entarco SA | The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer |
| US9913824B2 (en) * | 2010-01-25 | 2018-03-13 | Elanco Us Inc. | Methods for internally controlling or treating equine bot larvae |
| JP2013542737A (ja) * | 2010-11-05 | 2013-11-28 | イーライ リリー アンド カンパニー | 昆虫侵入を阻害するための方法 |
| ITMI20111945A1 (it) * | 2011-10-26 | 2013-04-27 | Zapi Ind Chimiche Spa | Formulazione in forma idonea a veicolare un quantitativo dosato di una sostanza attiva |
| CN103125501A (zh) * | 2011-11-30 | 2013-06-05 | 上海农乐生物制品股份有限公司 | 一种阿维菌素·多杀霉素水乳剂及其制备方法 |
| TW201416077A (zh) * | 2012-07-26 | 2014-05-01 | Lilly Co Eli | 單一劑量口服調配物及使用殺外寄生蟲劑賜諾殺（ｓｐｉｎｏｓａｄ）以治療貓之方法 |
| AU2013345149B2 (en) | 2012-11-14 | 2016-10-27 | Elanco Us Inc. | Ectoparasiticidal methods and formulations |
| WO2020012406A1 (en) * | 2018-07-11 | 2020-01-16 | Jubilant Generics Limited | Veterinary dosage forms |
| CN109221133A (zh) * | 2018-09-28 | 2019-01-18 | 绩溪农华生物科技有限公司 | 一种多杀菌素增效水乳剂及其制备方法 |
| JP2024511953A (ja) * | 2021-03-11 | 2024-03-18 | イン ザ ボウル アニマル ヘルス，インコーポレーテッド | 哺乳動物においてダニの侵入を防除するための餌および方法 |
| EP4304571A4 (en) * | 2021-03-11 | 2025-01-22 | In the Bowl Animal Health, Inc. | Oral canine feed and methods for controlling flea infestations in a canine |
| CN117500498A (zh) * | 2021-03-11 | 2024-02-02 | 碗中动物健康公司 | 用于控制哺乳动物中的蚤和蜱侵袭的方法 |
| WO2022271924A1 (en) * | 2021-06-25 | 2022-12-29 | In The Bowl Animal Health, Inc. | Oral feline feed and methods for controlling flea infestations in a feline |
| JP2024524995A (ja) * | 2021-06-25 | 2024-07-09 | イン ザ ボウル アニマル ヘルス，インコーポレーテッド | 経口のネコ科動物の飼料およびネコ科動物におけるノミの侵入を制御する方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US576253A (en) * | 1897-02-02 | Manhole-cover | ||
| PE5591A1 (es) | 1988-12-19 | 1991-02-15 | Lilly Co Eli | Un nuevo grupo de compuestos de macrolida |
| US5362634A (en) | 1989-10-30 | 1994-11-08 | Dowelanco | Process for producing A83543 compounds |
| JPH0375316A (ja) * | 1989-08-18 | 1991-03-29 | Tokyo Gas Denro Kk | 熱処理炉 |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5227295A (en) | 1991-11-08 | 1993-07-13 | Dowelanco | Process for isolating A83543 and its components |
| US5202242A (en) | 1991-11-08 | 1993-04-13 | Dowelanco | A83543 compounds and processes for production thereof |
| US5539089A (en) | 1991-11-08 | 1996-07-23 | Dowelanco | A83543 aglycones and pseudoglycones |
| US5591606A (en) | 1992-11-06 | 1997-01-07 | Dowelanco | Process for the production of A83543 compounds with Saccharopolyspora spinosa |
| ES2099604T3 (es) | 1993-03-12 | 1997-05-16 | Dowelanco | Nuevos compuestos a83543 y procedimiento para su produccion. |
| EP0837870B1 (en) | 1995-06-14 | 2002-07-24 | Dow AgroSciences LLC | Synthetic modification to spinosyn compounds |
| US5695776A (en) | 1996-03-12 | 1997-12-09 | Fmc Corporation | Termite bait apparatus having grooves |
| US6001981A (en) * | 1996-06-13 | 1999-12-14 | Dow Agrosciences Llc | Synthetic modification of Spinosyn compounds |
| GB9624501D0 (en) * | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Insecticial compositions and method |
| JPH11139912A (ja) * | 1997-11-06 | 1999-05-25 | Nissan Chem Ind Ltd | 安定化される農薬組成物 |
| GB2380132B (en) * | 1997-12-23 | 2003-05-07 | Syngenta Participations Ag | Use of macrolides in pest control |
| KR100641778B1 (ko) | 1998-07-02 | 2006-11-06 | 일라이 릴리 앤드 캄파니 | 인간 이 억제 제제 |
| WO2000060940A1 (en) | 1999-04-12 | 2000-10-19 | Dow Agrosciences Llc | Aqueous dispersions of agricultural chemicals |
| AU770542B2 (en) | 1999-08-12 | 2004-02-26 | Eli Lilly And Company | Topical organic ectoparasiticidal formulations |
| WO2001011961A1 (en) | 1999-08-12 | 2001-02-22 | Eli Lilly And Company | Control of ectoparasites using spinosyns |
| US6455504B1 (en) | 1999-09-13 | 2002-09-24 | Dow Agrosciences Llc | Pesticidal macrolides |
| AUPQ441699A0 (en) | 1999-12-02 | 2000-01-06 | Eli Lilly And Company | Pour-on formulations |
-
2000
- 2000-08-02 WO PCT/US2000/019557 patent/WO2001011963A1/en not_active Ceased
- 2000-08-02 NZ NZ516790A patent/NZ516790A/xx not_active IP Right Cessation
- 2000-08-02 AU AU67476/00A patent/AU775488B2/en not_active Expired
- 2000-08-02 EP EP00955247A patent/EP1207756B1/en not_active Expired - Lifetime
- 2000-08-02 DE DE201112100022 patent/DE122011100022I1/de active Pending
- 2000-08-02 PT PT00955247T patent/PT1207756E/pt unknown
- 2000-08-02 MX MXPA02001505A patent/MXPA02001505A/es active IP Right Grant
- 2000-08-02 JP JP2001516326A patent/JP5046455B2/ja not_active Expired - Lifetime
- 2000-08-02 DE DE60027575T patent/DE60027575T2/de not_active Expired - Lifetime
- 2000-08-02 US US10/049,345 patent/US6664237B1/en not_active Expired - Lifetime
- 2000-08-02 IL IL14782800A patent/IL147828A0/xx active IP Right Grant
- 2000-08-02 BR BRPI0013116-4A patent/BR0013116B1/pt not_active IP Right Cessation
- 2000-08-02 CA CA002379329A patent/CA2379329C/en not_active Expired - Lifetime
- 2000-08-02 ES ES00955247T patent/ES2261229T3/es not_active Expired - Lifetime
- 2000-08-02 HU HU0202825A patent/HUP0202825A2/hu unknown
- 2000-08-02 DK DK00955247T patent/DK1207756T3/da active
- 2000-08-02 KR KR1020027001773A patent/KR100706146B1/ko not_active Expired - Fee Related
- 2000-08-02 AT AT00955247T patent/ATE324039T1/de active
- 2000-08-09 CO CO00059545A patent/CO5410187A1/es not_active Application Discontinuation
- 2000-08-11 MY MYPI20003662A patent/MY125485A/en unknown
- 2000-08-11 TW TW089116161A patent/TWI244373B/zh not_active IP Right Cessation
-
2002
- 2002-01-22 ZA ZA200200565A patent/ZA200200565B/en unknown
- 2002-01-24 IL IL147828A patent/IL147828A/en unknown
- 2002-02-11 NO NO20020686A patent/NO20020686L/no not_active Application Discontinuation
-
2006
- 2006-06-29 CY CY20061100888T patent/CY1105000T1/el unknown
-
2011
- 2011-05-24 BE BE2011C013C patent/BE2011C013I2/fr unknown
- 2011-05-24 FR FR11C0017C patent/FR11C0017I2/fr active Active
- 2011-09-29 JP JP2011214050A patent/JP5427217B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2261229T3 (es) | Uso de spinosad o de una formulacion que comprende spinosad. | |
| ES2311677T3 (es) | Utilizacion de antagonistas de canales de sodio neuronales junto con amitraz para el control de los ectoparasitos en los animales homeotermos. | |
| AU2010246096B2 (en) | Ectoparasiticidal methods and formulations | |
| ES2315740T3 (es) | Formulaciones ectoparasiticidas de espinosinas y pesticidas de azol. | |
| US11375717B2 (en) | Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals | |
| WO2001011962A1 (en) | Topical treatment for insect pests in companion animals | |
| JP6952678B2 (ja) | ディロフィラリア症の拡大を抑制するためのネオニコチノイドとピレスロイドとの組合せ | |
| US9220719B2 (en) | Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad | |
| EP2529628A1 (en) | A controlled-release pesticide system for a composition | |
| US20230414644A1 (en) | Oral canine feed and methods for controlling flea infestations in a canine | |
| ES2341138T3 (es) | Composicion con actividad antiparasitaria mejorada. | |
| Singh et al. | Chemotherapeutics for control and treatment of ectoparasites in companion animals | |
| AU2013273709B2 (en) | Ectoparasiticidal methods and formulations | |
| KR20230161995A (ko) | 포유동물에서 진드기 감염을 제어하는 사료 및 방법 | |
| MacDonald | Which parasiticides when? |